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Edited by Gunnar von Heijne and Anders LiljasAbstract Transcriptional regulation in eukaryotes involves
structurally and functionally distinct nuclear RNA polymerases,
corresponding general initiation factors, gene-speciﬁc (DNA-
binding) regulatory factors, and a variety of coregulatory factors
that act either through chromatin modiﬁcations (e.g. histone
acetyltransferases and methyltransferases) or more directly
(e.g. Mediator) to facilitate formation and function of the preini-
tiation complex. Biochemical studies with puriﬁed factors and
DNA versus recombinant chromatin templates have provided in-
sights into the nature and mechanism of action of these factors,
including pathways for their sequential function in chromatin
remodeling and preinitiation complex formation/function (trans-
cription) steps and a possible role in facilitating the transition
between these steps.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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methyltransferases1. Introduction and historical perspective
Eukaryotic genomes are complex (up to 25 000 genetic loci
in human) and organized within compact nucleoprotein (chro-
matin) structures. The mechanisms by which individual genes
are activated are of intense interest and physiological impor-
tance, and studies over the past 35 years have revealed several
levels of control [1].
First, eukaryotes contain three functionally distinct classes
of nuclear RNA polymerases [2] that selectively transcribe
large ribosomal RNA genes (RNA polymerase I), protein-
coding and some small structural RNA genes (RNA polymer-
ase II) and tRNA, 5S RNA and other small structural RNA
genes (RNA polymerase III) [3,4]. These speciﬁcities are re-
ﬂected in the structurally distinct subunit compositions of
the three RNA polymerases [5], which contain both common
subunits and unique subunits related to those of the bacterial
RNA polymerase [6], and allow for independent global regula-
tion of the major classes of RNA.
Second, eukaryotic cells contain RNA polymerase-speciﬁc
general initiation factors that, despite the structural complexityE-mail address: roeder@rockefeller.edu (R.G. Roeder).
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doi:10.1016/j.febslet.2004.12.007of the enzymes (14, 12 and 17 subunits in RNA polymerases I,
II and III, respectively), are necessary for accurate transcrip-
tion initiation on corresponding core promoter elements by
puriﬁed RNA polymerases [7–11]. These factors are now
known to include TFIIIC and TFIIIB for RNA polymerase
III [reviewed in 12]; TFIIA, TFIIB, TFIID, TFIIE, TFIIF
and TFIIH for RNA polymerase II [reviewed in 13]; and sev-
eral factors for RNA polymerase I [reviewed in 14]. Following
identiﬁcation of core promoter recognition factors (TFIIIC for
class III and TFIID for class II promoters), mechanistic stud-
ies revealed pathways for the ordered assembly of initiation
factors and RNA polymerases into corresponding preinitiation
complexes (PICs) [15–18] (Figs. 1, left, and 2, right). The struc-
tural complexity of the basic preinitiation complexes (25 and
44 polypeptides, respectively, for RNA polymerases III and II)
is remarkable; and a variety of biochemical and genetic analy-
ses have provided much detail regarding the structure and
function of the individual polypeptides during PIC formation
and during subsequent transcription initiation and post-initia-
tion events [12–14]. In the case of RNA polymerase II, addi-
tional insights into PIC formation and RNA polymerase
function have been provided by structural studies of TBP-
TATA and higher order complexes [reviewed in 19] and of
RNA polymerase II itself [6,20].
Given that RNA polymerases and general initiation factors
are the ultimate targets of regulatory factors, these complex
assembly pathways oﬀer many points for regulatory interac-
tions. In this regard, it is important to note that while puriﬁed
RNA polymerases and corresponding general initiation factors
(comprising the basal transcription machinery) have an intrin-
sic ability to accurately transcribe DNA templates through
core promoter elements, thus allowing the fundamental tran-
scription mechanisms to be elucidated, these activities are gen-
erally suppressed in the cell by the packaging of DNA within
chromatin and by negative cofactors that directly interfere
with the function of the basal transcription factors (Fig. 3).
As discussed below, this imposes requirements for transcrip-
tional activators and corresponding cofactors that act in a
gene-speciﬁc manner both to reverse the repression (anti-
repression) and to eﬀect a net activation above the intrinsic
activity of the basal transcription machinery (Fig. 3).
Third, eukaryotes contain diverse sequence-speciﬁc DNA
binding transcriptional regulatory factors that facilitate RNA
polymerase function on corresponding target genes. The 5S
gene-speciﬁc TFIIIA was the ﬁrst of these to be identiﬁed as
such, puriﬁed and cloned [21,22], and also represents the pro-
totype zinc ﬁnger protein [23]. [Zinc ﬁnger proteins are theblished by Elsevier B.V. All rights reserved.
Fig. 1. General initiation factors and PIC assembly pathways for class
III genes with internal promoter elements, and activation by a gene-
speciﬁc factor. On the tRNA gene promoter, assembly of a functional
PIC containing RNA polymerase III and general initiation factors
(yellow) is nucleated by stable binding of TFIIIC to the Box A and Box
B elements. In contrast, assembly of a PIC on the divergent promoter
of the 5S RNA gene is more highly regulated and requires prior
binding to Box A and Box C of the 5S gene-speciﬁc activator TFIIIA,
which interacts with and stabilizes TFIIIC binding. For both genes,
TFIIIB is recruited by TFIIIC and RNA polymerase III is recruited by
TFIIIB and TFIIIC. Solid black bars indicate interactions between
RNA polymerase III and the various factors. NTP, ribonucleoside
triphosphates. From [1].
Fig. 2. General initiation factors and PIC assembly pathway for class II ge
speciﬁc factors and interacting cofactors. Assembly of a PIC containing RN
binding of TFIID to the TATA element of the core promoter. A model for
binding of regulatory factors to distal control elements; (ii) regulatory factor
additional factor interactions; and (iii) regulatory factor interactions with co
interactions, recruitment or function of the general transcription machinery.
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regulatory proteins in the human genome; and studies of their
DNA recognition mechanism have allowed the design of novel
gene-selective targeting proteins [24]]. Mechanistically, TFIIIA
was shown to facilitate transcription of the 5S gene by RNA
polymerase III through interactions with TFIIIC, which other-
wise does not bind to the 5S promoter; this in turn facilitates
TFIIIB and RNA polymerase III recruitment [15] (Fig. 1,
right). While distinct from the activation mechanism in pro-
karyotes, involving direct activator-RNA polymerase interac-
tions [25], this mechanism (involving indirect eﬀects on RNA
polymerase) has proved to be general in eukaryotes and allows
additional regulatory inputs. Following the paradigm estab-
lished by TFIIIA for eukaryotes, a large number of se-
quence-speciﬁc DNA-binding regulatory factors, often with
distinct DNA-binding and activation (or repression) domains,
have been identiﬁed and characterized both structurally [26]
and functionally. The vast majority of these are involved in
the regulation of the large group of protein-coding genes tran-
scribed by RNA polymerase II.
Fourth, the DNA-binding factors that regulate the tran-
scription of protein coding genes act in conjunction with an
expanding group of cofactors that act either through modiﬁca-
tions of chromatin structure or, more directly, to regulate for-
mation or function (transcription initiation or elongation) of
the preinitiation complex (Fig. 2). The requirements for cofac-
tors involved more directly in transcription [reviewed in 27] are
somewhat surprising in view of the speciﬁcity intrinsic to the
various DNA-binding regulatory factors, the structural com-nes with a TATA-containing core promoter, and regulation by gene-
A polymerase II and general initiation factors (yellow) is nucleated by
the regulation of PIC assembly and function involves, sequentially: (i)
interactions with cofactors that modify chromatin structure to facilitate
factors that act after chromatin remodeling to facilitate, through direct
TAFs, TBP-associated factors. Adapted from [1] and [23].
Fig. 3. States of promoter activity deﬁned by in vitro transcription
assays. A given DNA template exhibits an intrinsic basal transcription
activity with puriﬁed RNA polymerase II and puriﬁed general
transcription factors (GTFs). This activity can be repressed by general
negative cofactors such as NC2 (which interacts with TBP to prevent
TFIIB interactions, [27]) and by pre-assembly of the DNA template
into a chromatin structure, generating a more physiological repressed
or ground state. An activated state is reached in response to gene-
speciﬁc (DNA-bound) activators and various positive cofactors, either
from the intrinsic basal state or from the repressed state. The overall
level of induction in response to activators thus depends on the extent
to which the basal activity is repressed. Activation from the repressed
state can be viewed as a two step process involving an anti-repression
step that restores activity to the intrinsic basal level and a net-
activation step that leads to an overall net increase in activity above the
basal level; and the two steps may involve diﬀerent positive cofactors.
The in vitro observations are consistent with the view that activation in
vivo is not simply an anti-repression phenomenon. The model also
applies to the action of gene-speciﬁc DNA-bound repressors (and
corepressors) acting directly on general factors or on a chromatin
template. Adapted from [23].
Fig. 4. Model for PGC-1a function in both chromatin modiﬁcation
and preinitiation complex assembly/function steps and in facilitating
the transition between these steps. In an initial chromatin modiﬁcation
step, PPARc binds to the PPRE element in conjunction with its binding
partner RXR (not shown) and through direct interactions recruits p300
and PGC-1a; PGC-1 in turn interacts with p300 and stimulates p300-
mediated acetylation of promoter proximal nucleosomal histones. In a
subsequent step, the TRAP/Mediator is recruited to the promoter
through interactions (via the TRAP220 subunit) with PPARc and
PGC-1a that lead to p300 displacement; and subsequent TRAP/
Mediator-dependent transcription activation by PPARc is stimulated
R.G. Roeder / FEBS Letters 579 (2005) 909–915 911plexity of their ultimate target (the basal transcription machin-
ery), and documented interactions between regulatory factors
and components of the basal transcription machinery [re-
viewed in 13 and 28]. However, this additional layer of com-
plexity again allows a variety of novel regulatory
mechanisms. Select transcriptional coactivators are the main
subject of this minireview and are discussed further below.
by PGC-1a. Since PGC-1a interacts with p300 through its N-terminus
(N), with PPARc through an adjacent region and with TRAP220
through its C-terminus (C), concomitant interactions are possible and
may lead to formation of a transient intermediate that facilitates, in
conjunction with the modiﬁed chromatin structure, cofactor exchange
(TRAP/Mediator for p300) on promoter-bound PPARc and the
transition from chromatin remodeling to transcription states. As
TRAP220 and p300 both show primary interactions (through LXXLL
motifs) with a common (AF2) domain in PPARc, the TRAP220
interactions may facilitate p300 displacement from PPARc following
histone modiﬁcation. Red triangle, PPARc ligand. Based on [72].2. Transcriptional coactivator functions through the basal
transcriptional machinery: pre-eminent role of the Mediator
complex
Early studies of activator functions in systems reconstituted
with DNA templates and puriﬁed RNA polymerase II and cor-
responding general initiation factors revealed that additional
‘‘coactivator’’ [29] or ‘‘mediator’’ [30] activities were required
for activator function but not for basal (activator-indepen-
dent) transcription. In human cells, the USA (Upstream Stim-
ulatory Activity) coactivator activity [29] was resolved into anumber of negative cofactors and positive cofactors that act
jointly both to selectively repress basal transcription and to
facilitate activator-dependent transcription [reviewed in 27]
912 R.G. Roeder / FEBS Letters 579 (2005) 909–915(Figs. 2 and 3). One of the positive cofactors (PC2) was later
identiﬁed as a form of the human Mediator complex [31].
The human Mediator is a counterpart of the yeast Mediator,
which was ﬁrst identiﬁed, as a deﬁned complex, through an
association with RNA polymerase II and found to contain a
variety of genetically identiﬁed coactivators [32]. Some of these
latter coactivators (the SRBs) had earlier been identiﬁed
through genetic interactions with RNA polymerase II and
shown to physically associate with RNA polymerase II [33].
Recent considerations have pointed to a strong conservation
of Mediator structure and function from yeast to human.
Human Mediator was ﬁrst identiﬁed, as a structurally de-
ﬁned complex, through a stable intracellular thyroid hor-
mone-dependent association with thyroid hormone receptor
(TR) [34]. Further, this TR-associated protein (TRAP) com-
plex was shown to be necessary for TR-dependent transcrip-
tion from DNA templates by RNA polymerase II and
cognate general initiation factors [34]. The 220 KDa
TRAP220/MED1 subunit of TRAP/Mediator was identiﬁed
as a general nuclear receptor-interacting subunit [35,36], and
further shown, by analysis of TRAP220-mutant/deﬁcient com-
plexes, to be responsible for binding of the entire Mediator
complex to nuclear receptors [37,38]. These interactions were
shown to be mediated through TRAP220/MED1 LXXLL mo-
tifs, similar to those found in other nuclear receptor-interact-
ing coactivators, and a ligand-dependent activation function
2 (AF2)-containing hydrophobic cleft in nuclear receptors [re-
viewed in 39]. Studies with TRAP220/MED1 null ﬁbroblasts
(derived from TRAP220/MED1 knockout embryos) conﬁrmed
a speciﬁc physiological role for TRAP220/MED1 in nuclear
receptor function [40] and in nuclear receptor (PPARc)-depen-
dent diﬀerentiation of ﬁbroblasts to adipocytes [37]. These
observations provided a clear indication of Mediator function
through a mechanism that involves a primary (initial) interac-
tion with a transcriptional activator, as well as activator/gene-
selective functions for at least one Mediator subunit.
Human Mediator complexes related or equivalent to
TRAP/Mediator were subsequently isolated (by other ap-
proaches) and characterized by us and by others [reviewed
in 41]. These studies have provided additional evidence that
human Mediator is generally required for activator function,
consistent with yeast genetic studies [42], and that distinct
activators target speciﬁc Mediator subunits [reviewed in
41,43]. Beyond the seminal TRAP220/MED1 studies de-
scribed above, this is most clearly indicated by genetic studies
showing that ablation of the Elk-1- and E1A-interacting Sur2/
MED23 subunit leads to selective loss of Elk-1 and E1A func-
tion and Mediator binding [44] and by biochemical studies
showing that the p53-interacting TRAP80/MED17 subunit
selectively (amongst all Mediator subunits) crosslinks to p53
in the context of an intact (p53-bound) Mediator complex
(S. Yamamura and R.G. Roeder, unpublished observations).
Interestingly, just as cognate ligands cause conformational
changes in nuclear receptors [39] that enhance Mediator inter-
actions [34], mitogen-induced phosphorylation (through MAP
kinase) of Elk1 [44] and DNA-damage-induced phosphoryla-
tion (apparently through ATM/ATR) of p53 (S. Yamamura
and R.G. Roeder, unpublished observations) facilitate corre-
sponding interactions with Mediator. Hence, it may be antic-
ipated that pathways leading either to increased levels of
activators or to activation of regulatory factors may act via
Mediator.How activator-bound Mediator facilitates formation or
function of the preinitiation complex is also a question of
major interest. The identiﬁcation of RNA polymerase II-
Mediator complexes in extracts from yeast [32,33] and, more
recently, human cells [45] is indicative of RNA polymerase
II-Mediator interactions that may facilitate RNA polymerase
II recruitment, although recent studies have demonstrated
that Mediator and RNA polymerase II recruitment occur
in temporally distinct steps in vivo [46,47]. A role for Medi-
ator in RNA polymerase II recruitment and/or subsequent
function is also consistent with the demonstration of activa-
tor-independent eﬀects of Mediator on basal transcription in
vitro [32,48,49]. In vitro studies have suggested that yeast
Mediator remains promoter-associated following the primary
transcription initiation event, and thus may facilitate subse-
quent reinitiation by RNA polymerase II [50]. An extension
of this analysis to human systems has indicated that whereas
the entire Mediator complex is recruited to the promoter by
at least one activator (p53), transcription initiation results in
promoter retention only of the Mediator subcomplex PC2
[45]. Related, PC2 and an equivalent S.pombe Mediator
subcomplex [51], which both lack the SRB8-11 module,
show stable interactions with intact RNA polymerase II,
whereas complete Mediator complexes do not (at least in
solution). However, these observations do not exclude the
possibility of a transient (intermediate) Mediator-RNA poly-
merase II complex, whose formation could be facilitated by
other factors.
Along with our original identiﬁcation of a stable intracellu-
lar interaction of thyroid hormone receptor with an intact
Mediator [34], these results suggest a transcription activation
mechanism involving activator-mediated recruitment of the
entire TRAP/Mediator complex (over 25 subunits) to the pro-
moter and subsequent conversion of bound TRAP/Mediator
to PC2 via loss of the SRB8-11 module (TRAP240/MED13/
SRB9-TRAP230/MED12/SRB8-SRB10/CDK8-SRB11/cyclin
C). This might occur at some step during PIC formation (e.g.,
RNA polymerase II recruitment) or during a subsequent step
(e.g., initiation or promoter clearance by RNA polymerase
II). Conformational changes in the complete Mediator [52]
leading to loss of the SRB8-11 module and enhanced RNA
polymerase II interactions might conceivably be induced by
Mediator interactions with activator [53] and/or components
of the preinitiation complex. With loss of the SRB8-11 module
and retention of the PC2 complex and several general initia-
tion factors after the ﬁrst initiation event, the promoter would
be primed for eﬃcient reinitiation events by cycling RNA poly-
merase II.
Thus, TRAP/Mediator may function dynamically at two lev-
els – both in promotion of PIC assembly in concert with the
activator and in modulation of RNA polymerase II activity
following a structural/topological change. This diﬀers from an-
other model involving promoter recruitment of an active
CRSP/PC2 complex rather than an inactive complete Media-
tor complex [53].3. Transcriptional coactivator functions through chromosomal
histone modiﬁcations
Apart from a DNA packaging function, nucleosomal and
higher order chromatin structures provide a barrier to the
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intrinsic ability to transcribe histone-free DNA templates
through interactions at core promoters [reviewed in 54]. Thus,
early studies with puriﬁed RNA polymerase II and general ini-
tiation factors [55,56] or with nuclear extracts [57] showed that
prior assembly of DNA templates into chromatin prevented
subsequent transcription, whereas prior formation of a com-
plete PIC or a TFIID-promoter complex prior to chromatin
assembly facilitated subsequent transcription initiation. His-
tone ablation studies in yeast conﬁrmed a general repressive
function for histones and further indicated that some activa-
tors act mainly to overcome the general histone-mediated
repression (anti-repression), whereas others also eﬀect a level
of activation beyond that observed by histone ablation (anti-
repression plus net activation) [58] (see Fig. 3).
Based on a wealth of studies over the past decade, it is now
widely accepted that a variety of modiﬁcations (including acet-
ylation, methylation, phosphorylation, and ubiquitylation) on
the N-terminal tails of histones are correlated with, and pre-
sumably causal for, speciﬁc gene activation and repression
events [reviewed in 59–62]. Among the landmark studies that
catalyzed the ﬂurry of activity in this ﬁeld were those revealing,
from puriﬁcation and cognate cDNA cloning/sequence analy-
ses, that a histone acetyltransferase (HAT) and a histone
deacetylase (HDAC) were equivalent, respectively, to a genet-
ically deﬁned coactivator (Gcn5p) and a genetically deﬁned
corepressor (Rpd3p) [63,64]. Studies to date have now de-
scribed numerous cofactors that eﬀect the above-mentioned
modiﬁcations and that have been linked to various gene activa-
tion and repression (including epigenetic) mechanisms [re-
viewed in 59–62]. Importantly, however, in most cases the
histone modiﬁcations have only been correlated with the
genetic regulatory events and not unequivocally proved to be
causal for these events. This is an important point since, at
least in metazoans, many transcriptional regulatory factors
are also functional substrates for the histone modifying cofac-
tors – as ﬁrst demonstrated by our studies of p53 [65].
Coupled with the ability to recapitulate transcriptional
activation dependent on histone-modifying enzymes/cofactors
in cell free systems [reviewed in 66], the ability to assemble
chromatin templates with puriﬁed/recombinant chromatin
assembly factors [67] and puriﬁed recombinant histones [68]
has allowed us to establish systems for detailed mechanistic
analyses and to address some fundamental questions
[66,69]. An initial study showed, as expected, that assembly
of chromatin with recombinant core histone octamers com-
pletely represses both basal and activator-dependent tran-
scription and, further, that chromatin templates assembled
with recombinant histones completely lacking the histone
tails remain fully repressed [66]. The latter result was surpris-
ing in view of earlier studies indicating that proteolyzed
chromatin templates lacking histone tails are derepressed
and that histone tails are critical for internucleosomal inter-
actions and higher order chromatin folding and attendant
repression mechanisms [reviewed in 66]. Hence, our newer
studies clearly demonstrated a transcription repression mech-
anism that is intrinsic to the structure of the core nucleosome
and that must operate beyond any mechanism(s) related to
histone tail-dependent internucleosomal interactions and
higher order folding. In a further analysis of p300-dependent
transcription activation using recombinant chromatin tem-
plates with selected histone tail deletions, it was shown thatthe H2A and H2B tails are dispensable for activation
whereas the H3 and H4 tails are jointly required [66,69].
The former result likely reﬂects the absence of any higher or-
der folding of the small circular chromatin templates studied,
whereas the latter result indicates essential non-redundant
functions for the H3 and H4 tails in p300-dependent tran-
scription. Moreover, and most importantly, an analysis of
templates with histone tail mutations that preclude acetyla-
tion at the physiological acetylation sites indicated that acet-
ylation of H3 and H4 tail residues (lysines) is essential for
p300-dependent activation [66,69]. These observations are
consistent with the additional observations (reviewed in 66)
of activator-dependent, targeted histone acetylation by p300.
Further emphasizing the utility and power of the recombi-
nant chromatin template assays, our recent studies have shown
p53-dependent transcription that is also dependent upon p300
and associated H3 and H4 acetylation events, protein arginine
methyl transferase 1 (PRMT1) and associated H4 methylation
events, or PRMT4/CARM1 and associated H3 methylation
events [69]. These studies not only established independent
functions dependent upon histone modiﬁcations for these his-
tone modifying enzymes/coactivators, but ordered cooperative
functions as well. They were further validated by demonstra-
tion of the induced accumulation of these (and other) coactiva-
tors, and associated histone modiﬁcations, on a p53 target
gene during a DNA damage response [69]. There are several
signiﬁcant features to these studies that deserve emphasis.
First, they provide the ﬁrst formal proof that histone modiﬁca-
tions per se, rather than (or in addition to) other transcription
factor modiﬁcations, are essential for the coactivator func-
tions. Second, and in contrast to cellular studies where indirect
eﬀects or contributions of endogenous cofactors cannot be ex-
cluded, they show direct, independent eﬀects of the individual
p300, PRMT1 and CARM1 coactivators, as well as direct
cooperative eﬀects. Third, they provide a basis for further
investigations of the ultimate eﬀects (mechanisms of action)
of the various histone modiﬁcations. Based on past studies
showing interactions of bromodomain-containing proteins
with acetylated histone lysines and chromodomain-containing
proteins with speciﬁc methylated histone lysines [reviewed in
62], it is anticipated that the modiﬁed histone residues may
serve as recognition sites for other essential factors involved
in chromatin remodeling [e.g., the ATP-dependent chromatin
remodelers, reviewed in 70] or factors involved in transcription
initiation and elongation (e.g., Mediator and general transcrip-
tion factors).
An ultimate objective of our studies, which will facilitate
identiﬁcation of relevant factor interactions and corresponding
mechanisms, is the reconstitution of a fully biochemically de-
ﬁned cell free system that mediates robust activator-dependent
transcription of chromatin templates. To date, all recombinant
chromatin templates have been transcribed in nuclear extracts,
subsequent to activator-dependent chromatin remodeling/
modiﬁcation, owing to an inability of the puriﬁed factors that
are suﬃcient for activator-dependent transcription from DNA
templates to eﬀectively transcribe chromatin templates. Signif-
icantly, we have recently identiﬁed and extensively puriﬁed a
factor(s) that is necessary, along with RNA polymerase II,
cognate general initiation factors, Mediator, and the ATP-
dependent chromatin remodeling activity (ACF) that is carried
over from chromatin assembly, for robust p300-dependent
transcriptional activation from a model chromatin template
914 R.G. Roeder / FEBS Letters 579 (2005) 909–915(M. Guermah and R.G. Roeder, unpublished observations).
Studies of the nature, functional speciﬁcity (for diﬀerent acti-
vators and diﬀerent histone-modifying cofactors), and mecha-
nism of action of this factor(s) are underway.
The in vitro studies of transcription activation from DNA
versus chromatin templates have led to a general model
[27,35,39] involving activator-dependent recruitment and
function of chromatin remodeling/modifying factors followed
by activator-dependent formation and function of the preini-
tiation complex through a mechanism(s) involving additional
cofactors such as Mediator (Fig. 2). A major question con-
cerns the mechanism(s) involved in transitions from activa-
tor-dependent chromatin remodeling/modiﬁcation steps to
activator-dependent PIC formation/function, especially in
cases (e.g., nuclear receptors) where chromatin remodelers/
modiﬁers and Mediator interact with identical or overlapping
surfaces (activation domains) in the activators [reviewed in
39]. The transitions could be a simple matter of equilibrium
reactions, with both types of cofactors interacting with pro-
moter bound activators within chromatin but with Mediator
interactions being unproductive until chromatin remodeling/
modifying factor interactions have resulted in chromatin
structural changes that facilitate subsequent Mediator inter-
action and PIC formation through cooperative stabilizing
interactions [43].
Another appealing possibility is the involvement of addi-
tional cofactors that interact physically and functionally
both with chromatin remodeling/modifying cofactors and
with Mediator or PIC components. Of signiﬁcance in this re-
gard is our recent demonstration that PGC-1a, an inducible
coactivator that interacts with nuclear receptors [reviewed in
71], interacts with and stimulates the function of both p300
and Mediator in nuclear receptor (PPARc)-dependent tran-
scription [72] (Fig. 4). The PGC-1a-enhanced Mediator func-
tion is evident on DNA templates in the absence of the p300
binding site in the N-terminal region of PGC-1a. However,
the eﬀect of PGC-1a on p300-dependent transcription from
a chromatin template requires both the N-terminal p300
interaction site and the C-terminal Mediator interaction site
on PGC-1a, thus suggesting that the eﬀect of PGC-1a on
p300 may be linked to the eﬀect on TRAP/Mediator. Along
with the presence of multiple interaction sites between the
various factors and largely non-overlapping interaction sites
for PPARc, p300 and TRAP220 on PGC-1a, this suggests a
model (Fig. 4) wherein PGC-1a may facilitate the transition
(including cofactor exchange) between a chromatin remodel-
ing step involving ligand-dependent binding of p300 to
PPARc and a later transcription activation step involving li-
gand-dependent binding of TRAP/Mediator to PPARc. It is
envisioned that alternative dynamic interactions of the vari-
ous components may both stabilize and enhance the func-
tion of the diﬀerent complexes and, perhaps through a
transient intermediate complex containing all components,
facilitate the transition between them. Of signiﬁcant interest
is whether PGC-1a will serve as a prototype for other cofac-
tors acting in conjunction with other transcriptional activa-
tors. Because gene activation in the cell may involve a
requisite sequence of events (e.g., chromatin modiﬁcations
prior to PIC formation), the use of biochemically deﬁned
systems in which partial reactions can be studied will be
essential for identiﬁcation and/or for elaborating the mecha-
nism(s) of action of such cofactors.4. Conclusions and perspectives
Beginning with the discovery of the three nuclear RNA
polymerases 35 years ago, biochemical (and more recently ge-
netic) studies have identiﬁed a remarkably complex general
transcription machinery and an equally complex array of
coregulatory factors that facilitate functional interactions of
DNA binding regulatory factors (numbering several thousand)
with this machinery on corresponding target genes. This com-
plex transcriptional apparatus appears to have evolved to facil-
itate the proper execution and regulation of the diverse and
ﬁnely tuned gene activation pathways that are critical for nor-
mal development, cell diﬀerentiation and homeostasis. This
complex apparatus allows (i) global control mechanisms for
the major classes of RNA, (ii) mechanisms to activate or re-
press genes packaged within natural chromatin structures,
(iii) multiple targets for the cooperative functions of combina-
tions of DNA-binding regulatory factors, (iv) mechanisms for
the integration of multiple signaling pathways and (v) a basis
for alternative or redundant gene activation and repression
pathways that may contribute to biological robustness [73].
Although they warrant extension (and validation) in more
physiological assays in cell and animal models, the biochemical
assays emphasized here have provided profound insights into
the nature and mechanism of action of the general transcrip-
tion machinery, gene speciﬁc regulatory factors, and diverse
cofactors. The recent development of systems for the assembly
and functional analysis of recombinant chromatin templates in
biochemically deﬁned systems, coupled with high resolution
structural studies, oﬀers the promise of an increasingly more
detailed picture of the diverse events that are necessary, upon
a given signal, to convert a repressed gene within a natural
chromatin structure to an actively transcribed state.
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